Literature DB >> 7488550

A new fibroblast growth stimulating activity from the human megakaryoblastic leukaemia cell line ELF-153: in vitro and in vivo findings.

H T Hassan1, A R Hanauske, E Lux, H D Kleine, M Freund.   

Abstract

Although the exact mechanism for the progression of myelofibrosis in acute megakaryoblastic leukaemia is unclear, certain humoral factors released from the proliferating megakaryoblasts that are unable to store these factors in their defective alpha-granules, including platelet derived growth factor (PDGF), fibroblast growth factors (FGF), platelet factor-4 (PF-4), transforming growth factor-beta (TGF-beta) and beta-thromboglobulin, could result in increased collagen synthesis by bone marrow fibroblasts. Recently, the human megakaryoblastic leukaemia cell line MEG-01 has been shown to produce both TGF-beta and PF-4 which have enhanced the growth of bone marrow fibroblasts. Therefore, we have examined the presence of a fibroblast growth stimulating activity and the humoral factors that might be responsible for it in the supernatant of the human megakaryoblastic leukaemia cell line ELF-153 recently established in our laboratory from a patient with acute myelofibrosis. A new fibroblast growth stimulating activity has been identified in the supernatant of the ELF-153 human megakaryoblastic leukaemia cell line that is independent of the percentage of fetal calf serum in NRK-49F fibroblast agar clonogenic assays and is not due to any of the known fibroblast growth stimulating humoral factors including PDGF, epithelial growth factor, TGF-alpha or beta, tumour necrosis factor-alpha, interleukin-1, 2, 4 or 6, FGF, fibronectin, PF-4 and factor VIII AG. Also, in vivo, subcutaneous injection of ELF-153 megakaryoblastic leukaemia cells into nude mice formed, in three out of the five mice after 6 weeks, subcutaneous tumours with a very rigid texture whose histological examination revealed dense infiltration by blast cells and pronounced reticular fibrosis. Immunohistochemistry demonstrated exclusive deposition of collagen III in the extracellular matrix whereas laminin and collagen IV were absent.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488550      PMCID: PMC1997200     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  30 in total

Review 1.  Pathogenesis of idiopathic myelofibrosis: role of growth factors.

Authors:  J T Reilly
Journal:  J Clin Pathol       Date:  1992-06       Impact factor: 3.411

2.  The effect of low affinity platelet factor 4 (LAPF4) secreted by human megakaryoblastic cell line (MEG-01) upon human bone marrow fibroblasts.

Authors:  N Tanabe; M Tanaka; M Ogura; Y Morishita; J Takamatu; H Saito
Journal:  Haematologica       Date:  1991 May-Jun       Impact factor: 9.941

3.  New insights into the regulation of megakaryocytopoiesis by haematopoietic and fibroblastic growth factors and transforming growth factor beta 1.

Authors:  Z C Han; S Bellucci; H Y Wan; J P Caen
Journal:  Br J Haematol       Date:  1992-05       Impact factor: 6.998

4.  Modulation of megakaryocytopoiesis by human basic fibroblast growth factor.

Authors:  H Avraham; N Banu; D T Scadden; J Abraham; J E Groopman
Journal:  Blood       Date:  1994-04-15       Impact factor: 22.113

5.  Bone marrow stromal fibroblasts secrete interleukin-6 and granulocyte-macrophage colony-stimulating factor in the absence of inflammatory stimulation: demonstration by serum-free bioassay, enzyme-linked immunosorbent assay, and reverse transcriptase polymerase chain reaction.

Authors:  S C Guba; C I Sartor; L R Gottschalk; Y H Jing; T Mulligan; S G Emerson
Journal:  Blood       Date:  1992-09-01       Impact factor: 22.113

6.  Interaction of fibroblast growth factor (FGF) with megakaryocytopoiesis and demonstration of FGF receptor expression in megakaryocytes and megakaryocytic-like cells.

Authors:  A Bikfalvi; Z C Han; G Fuhrmann
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

7.  Detection of platelet-specific protein mRNAs in different megakaryoblasts using the reverse transcriptase polymerase chain reaction.

Authors:  M Yasunaga; R Ryo; W Sugano; N Yamaguchi
Journal:  Leuk Lymphoma       Date:  1992-08

8.  Growth and differentiation of the human megakaryoblastic cell line (ELF-153): a model for early stages of megakaryocytopoiesis.

Authors:  M A Mouthon; M Freund; M Titeux; A Katz; J Guichard; J Breton-Gorius; W Vainchenker
Journal:  Blood       Date:  1994-08-15       Impact factor: 22.113

Review 9.  Angiogenic factors are hematopoietic growth factors and vice versa.

Authors:  A Bikfalvi; Z C Han
Journal:  Leukemia       Date:  1994-03       Impact factor: 11.528

10.  Acute megakaryoblastic leukemia with translocation t(1;22)(p13;q13) in a 10-week-old infant.

Authors:  S Washio; M Ido; E Azuma; M Fukui; T Shibata; S L Zhang; Y Komada; M Ito; T Koike; Y Kaneko
Journal:  Am J Hematol       Date:  1992-01       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.